Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial

Berger, 1993, Oral insulin 1922–1992: the history of continuous ambition and failure, 144 Zijlstra, 2014, Oral insulin reloaded: a structured approach, J Diabetes Sci Technol, 8, 458, 10.1177/1932296814529988 Rubin, 2009, Barriers to insulin injection therapy: patient and health care provider perspectives, Diabetes Educ, 35, 1014, 10.1177/0145721709345773 Arbit, 2004, The physiological rationale for oral insulin administration, Diabetes Technol Ther, 6, 510, 10.1089/1520915041705929 Cherrington, 2007, Insulin action on the liver in vivo, Biochem Soc Trans, 35, 1171, 10.1042/BST0351171 Iyer, 2010, Oral insulin—a review of current status, Diabetes Obes Metab, 12, 179, 10.1111/j.1463-1326.2009.01150.x Owens, 2013, Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetes, Diabetes Technol Ther, 15, 776, 10.1089/dia.2013.0081 Goldberg, 2003, Challenges for the oral delivery of macromolecules, Nat Rev Drug Discov, 2, 289, 10.1038/nrd1067 Aguirre, 2016, Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials, Adv Drug Deliv Rev, 106, 223, 10.1016/j.addr.2016.02.004 Leonard, 2006, Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET, Expert Opin Drug Deliv, 3, 685, 10.1517/17425247.3.5.685 Zijlstra, 2017, Effect of food intake on the absorption of oral basal insulin, Diabetologia, 60, S89 Maher, 2009, Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic, Adv Drug Deliv Rev, 61, 1427, 10.1016/j.addr.2009.09.006 Buckley, 2018, Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist, Sci Transl Med, 10, eaar7047, 10.1126/scitranslmed.aar7047 Zinman, 2012, Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long), Diabetes Care, 35, 2464, 10.2337/dc12-1205 Rosenstock, 2015, Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus) in patients with type 2 diabetes who were insulin-naive or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study), Diabetes Obes Metab, 17, 734, 10.1111/dom.12482 Seaquist, 2013, Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society, Diabetes Care, 36, 1384, 10.2337/dc12-2480 Meneghini, 2013, Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes, Diabetes Obes Metab, 15, 729, 10.1111/dom.12083 Fieller, 1954, Some problems in interval estimation, J Royal Stat Soc Series B (Methodological), 16, 175 Akbari, 2016, Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis, J Endocrinol Invest, 39, 215, 10.1007/s40618-015-0326-3 Lopes, 2015, Why most oral insulin formulations do not reach clinical trials, Ther Deliv, 6, 973, 10.4155/TDE.15.47 Fonte, 2013, Oral insulin delivery: how far are we?, J Diabetes Sci Technol, 7, 520, 10.1177/193229681300700228 Moore, 2018, Basal oral insulin analog I338 enhances meal-related hepatic glucose disposal, Diabetes, 67, A93 Moore, 2017, Liver-preferential effect of oral basal insulin 320 (i320) blunts hypoglycemia in response to overdosing, Diabetes, 66, A248 Schmidt, 2002, Food-drug interactions, Drugs, 62, 1481, 10.2165/00003495-200262100-00005 Vora, 2013, Variability of glucose-lowering effect as a limiting factor in optimizing basal insulin therapy: a review, Diabetes Obes Metab, 15, 701, 10.1111/dom.12087 Schellekens, 2010, The immunogenicity of therapeutic proteins, Discov Med, 9, 560 Fineberg, 2007, Insulin antibodies with pulmonary delivery of insulin, Diabetes Technol Ther, 9, S102, 10.1089/dia.2007.0207 Walsh, 2011, Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET), Ther Deliv, 2, 1595, 10.4155/tde.11.132 Ballarín-González, 2017, Identification of basolateral but no luminal distribution of insulin and IGF-1 receptors in gut epithelia, Diabetes, 66, A493 Hvid, 2017, Comparison of intracellular signalling downstream of the insulin receptor in the small intestine after intraintestinal or intravenous administration of insulin, Diabetes, 66, A672